Rock Springs Capital Management LP Acumen Pharmaceuticals, Inc. Transaction History
Rock Springs Capital Management LP
- $3.83 Billion
- Q1 2024
A detailed history of Rock Springs Capital Management LP transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 2,300,059 shares of ABOS stock, worth $4.92 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,300,059
Previous 2,300,059
-0.0%
Holding current value
$4.92 Million
Previous $8.83 Million
5.47%
% of portfolio
0.24%
Previous 0.22%
Shares
5 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
26.8MCall Options Held
319KPut Options Held
86.3K-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$7.31 Million4.42% of portfolio
-
Franklin Resources Inc San Mateo, CA3.4MShares$7.27 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.63MShares$5.63 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.9MShares$4.06 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$3.56 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $86.7M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...